Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety

Abdallah M. Beano
Mohammad A. Zmaili
Zaid H. Gheith
Ahmad M. Naser
Munther S. Momani
Al-Motassem F. Yousef
Ayman A. Zayed

June 2017

BackgroundMany Muslim type 2 diabetes mellitus (T2DM) patients choose to fast the month of Ramadan d...

Study of the metabolic effects of Ramadan fasting on patients with type 2 diabetes. Relation to glycemic control, hypoglycemic events and diabetic complications

Ismail, Azza
Meglaa, Magdy helmy
Badrah, Mai
Farghaly, Menna

May 2021

Background. The aim of this study is to evaluate the metabolic effects of Ramadan fasting on patient...

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Hassoun AAK
Pathan MF
Medlej RC
Alarouj M
Shaltout I
Chawla MS
Knap D
Vaz JA

July 2016

Ahmed AK Hassoun,1 Md Faruque Pathan,2 Rita C Medlej,3,4 Monira Alarouj,5 Inass Shaltout,6 Manoj S C...

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

Hassanein, M
Hanif, W
Malik, Waqar
Kamal, Ali
Geransar, P
Lister, N
Andrews, C
Barnett, Anthony

July 2011

Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim ...

Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan

Mehar, S
Devendra, D
Gohel, B
Bravis, V
Hui, E
Salih, S
Hassanein, M

January 2009

SummaryAims: To compare hypoglycaemic events, glycated haemoglobin (HbA1c) and changes in bodyweight...

Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan

Line P. Malha
Ghazi Taan
Mira S. Zantout
Sami T. Azar

February 2014

Objective To study the incidence of hypoglycemia, glycemic control and body weight changes in patien...

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

Ehab Mudher Mikhael

January 2016

Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a s...

Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis

Laura J. Gray (7605071)
J Dales (7693016)
EM Brady (7693019)
Kamlesh Khunti (171607)
W Hanif (7693022)
Melanie J. Davies (7155500)

April 2015

Aim: To determine which non-insulin glucose-lowering treatment regimens are most appropriate in peo...

The safety and effectiveness of non-insulin glucose lowering agents in the treatment of people with Type 2 Diabetes who observe Ramadan: A systematic review and meta-analysis

Laura J. Gray (7605071)
Jolyon Dales (7631678)
Emer M. Brady (7631681)
Kamlesh Khunti (171607)
Wasim Hanif (5225120)
Melanie J. Davies (7155500)

March 2015

Aims: To determine which non-insulin glucose lowering treatment regimens are most appropriate in peo...

Oral anti-diabetics in Ramadan

Islam, Najmul

May 2015

A large proportion of Muslim patients with type 2 diabetes fast during the month of Ramadan worldwid...

Strategies to make Ramadan fasting safer in type 2 diabetics:A systematic review and network meta-analysis of randomized controlled trials and observational studies

Lee, Shaun Wen Huey
Lee, Jun Yang
Tan, Christina San San
Wong, Chee Piau

January 2016

Ramadan is the holy month for Muslims whereby they fast from predawn to after sunset and is observed...

Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes

Alaaeldin Bashier
Azza Abdulaziz Khalifa
Elamin Ibrahim Abdelgadir
Maryam Ahmad Al Saeed
Amina Adil Al Qaysi
Murad Burhan Ali Bayati
Budoor Alemadi
Fawzi Bachet
Fatheya Alawadi
Mohammed Hassanein

March 2018

Objectives: Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) are a new class of antidiabetic drug...

Safety and Tolerability of Sodium Glucose Co-transporter -2 Inhibitors (SGLT2i) During Ramadan Fasting

Eid, Elsayed A.
Hussein, Abdelaziz M.
Ghazy, Hossam A.

November 2021

Background: Diabetic management during Ramadan fasting is a significant clinical challenge. Sodium g...

A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting

Tonyukuk, Vedia
Emral, Rifat
Cesur, Mustafa
Uysal, Ali Riza
Corapcioglu, Demet
Gursoy, Alptekin
Ozduman, Mine
Kamel, Nuri
Gonen, Sait
Yilmaz, Arif Ender
Bayram, Fahri

February 2007

Although diabetics may be exempted from Ramadan fasting, many patients still insist on this worship....

Guidelines for managing diabetes in Ramadan.

Ali, S
Davies, MJ
Brady, EM
Gray, LJ
Khunti, K
Beshyah, SA
Hanif, W

October 2016

BACKGROUND: Globally there are approximately 90 million Muslims with diabetes of which approximately...

Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety

Abdallah M. Beano
Mohammad A. Zmaili
Zaid H. Gheith
Ahmad M. Naser
Munther S. Momani
Al-Motassem F. Yousef
Ayman A. Zayed

June 2017

BackgroundMany Muslim type 2 diabetes mellitus (T2DM) patients choose to fast the month of Ramadan d...

Study of the metabolic effects of Ramadan fasting on patients with type 2 diabetes. Relation to glycemic control, hypoglycemic events and diabetic complications

Ismail, Azza
Meglaa, Magdy helmy
Badrah, Mai
Farghaly, Menna

May 2021

Background. The aim of this study is to evaluate the metabolic effects of Ramadan fasting on patient...

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Hassoun AAK
Pathan MF
Medlej RC
Alarouj M
Shaltout I
Chawla MS
Knap D
Vaz JA

July 2016

Ahmed AK Hassoun,1 Md Faruque Pathan,2 Rita C Medlej,3,4 Monira Alarouj,5 Inass Shaltout,6 Manoj S C...

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

Hassanein, M
Hanif, W
Malik, Waqar
Kamal, Ali
Geransar, P
Lister, N
Andrews, C
Barnett, Anthony

July 2011

Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim ...

Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan

Mehar, S
Devendra, D
Gohel, B
Bravis, V
Hui, E
Salih, S
Hassanein, M

January 2009

SummaryAims: To compare hypoglycaemic events, glycated haemoglobin (HbA1c) and changes in bodyweight...

Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan

Line P. Malha
Ghazi Taan
Mira S. Zantout
Sami T. Azar

February 2014

Objective To study the incidence of hypoglycemia, glycemic control and body weight changes in patien...

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

Ehab Mudher Mikhael

January 2016

Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a s...

Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis

Laura J. Gray (7605071)
J Dales (7693016)
EM Brady (7693019)
Kamlesh Khunti (171607)
W Hanif (7693022)
Melanie J. Davies (7155500)

April 2015

Aim: To determine which non-insulin glucose-lowering treatment regimens are most appropriate in peo...

The safety and effectiveness of non-insulin glucose lowering agents in the treatment of people with Type 2 Diabetes who observe Ramadan: A systematic review and meta-analysis

Laura J. Gray (7605071)
Jolyon Dales (7631678)
Emer M. Brady (7631681)
Kamlesh Khunti (171607)
Wasim Hanif (5225120)
Melanie J. Davies (7155500)

March 2015

Aims: To determine which non-insulin glucose lowering treatment regimens are most appropriate in peo...

Oral anti-diabetics in Ramadan

Islam, Najmul

May 2015

A large proportion of Muslim patients with type 2 diabetes fast during the month of Ramadan worldwid...

Strategies to make Ramadan fasting safer in type 2 diabetics:A systematic review and network meta-analysis of randomized controlled trials and observational studies

Lee, Shaun Wen Huey
Lee, Jun Yang
Tan, Christina San San
Wong, Chee Piau

January 2016

Ramadan is the holy month for Muslims whereby they fast from predawn to after sunset and is observed...

Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes

Alaaeldin Bashier
Azza Abdulaziz Khalifa
Elamin Ibrahim Abdelgadir
Maryam Ahmad Al Saeed
Amina Adil Al Qaysi
Murad Burhan Ali Bayati
Budoor Alemadi
Fawzi Bachet
Fatheya Alawadi
Mohammed Hassanein

March 2018

Objectives: Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) are a new class of antidiabetic drug...

Safety and Tolerability of Sodium Glucose Co-transporter -2 Inhibitors (SGLT2i) During Ramadan Fasting

Eid, Elsayed A.
Hussein, Abdelaziz M.
Ghazy, Hossam A.

November 2021

Background: Diabetic management during Ramadan fasting is a significant clinical challenge. Sodium g...

A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting

Tonyukuk, Vedia
Emral, Rifat
Cesur, Mustafa
Uysal, Ali Riza
Corapcioglu, Demet
Gursoy, Alptekin
Ozduman, Mine
Kamel, Nuri
Gonen, Sait
Yilmaz, Arif Ender
Bayram, Fahri

February 2007

Although diabetics may be exempted from Ramadan fasting, many patients still insist on this worship....

Guidelines for managing diabetes in Ramadan.

Ali, S
Davies, MJ
Brady, EM
Gray, LJ
Khunti, K
Beshyah, SA
Hanif, W

October 2016

BACKGROUND: Globally there are approximately 90 million Muslims with diabetes of which approximately...

Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety

Abdallah M. Beano
Mohammad A. Zmaili
Zaid H. Gheith
Ahmad M. Naser
Munther S. Momani
Al-Motassem F. Yousef
Ayman A. Zayed

June 2017

BackgroundMany Muslim type 2 diabetes mellitus (T2DM) patients choose to fast the month of Ramadan d...

Study of the metabolic effects of Ramadan fasting on patients with type 2 diabetes. Relation to glycemic control, hypoglycemic events and diabetic complications

Ismail, Azza
Meglaa, Magdy helmy
Badrah, Mai
Farghaly, Menna

May 2021

Background. The aim of this study is to evaluate the metabolic effects of Ramadan fasting on patient...

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Hassoun AAK
Pathan MF
Medlej RC
Alarouj M
Shaltout I
Chawla MS
Knap D
Vaz JA

July 2016

Ahmed AK Hassoun,1 Md Faruque Pathan,2 Rita C Medlej,3,4 Monira Alarouj,5 Inass Shaltout,6 Manoj S C...

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

Abstract

Extracted data

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

Abstract

Extracted data

Topics

Related items

Topics

Related items